Tradewinds Capital Management, LLC Bristol Myers Squibb CO Transaction History

Tradewinds Capital Management, LLC

$372 Million
Q3 2024

A detailed history of Tradewinds Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 1,254 shares of BMY stock, worth $68,117. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,254

Previous 1,239 1.21%

Holding current value

$68,117

Previous $51,000 25.49%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$39.66 - $51.75 $594 - $776	15 Added 1.21%	1,254 $64,000
Q2 2024 Jul 17, 2024	BUY	$40.25 - $52.99 $603 - $794	15 Added 1.23%	1,239 $51,000
Q1 2024 Apr 18, 2024	SELL	$47.98 - $54.4 $575 - $652	-12 Reduced 0.97%	1,224 $66,000
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $1,793 - $2,140	37 Added 3.09%	1,236 $63,000
Q3 2023 Oct 30, 2023	BUY	$57.89 - $64.73 $578 - $647	10 Added 0.84%	1,199 $69,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $637 - $707	10 Added 0.85%	1,189 $76,000
Q1 2023 Apr 10, 2023	BUY	$65.71 - $74.53 $525 - $596	8 Added 0.68%	1,179 $81,000
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $479 - $567	7 Added 0.6%	1,171 $0
Q3 2022 Oct 18, 2022	SELL	$0.13 - $76.84 $2 - $1,306	-17 Reduced 1.44%	1,164 $83,000
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $265,280 - $292,166	-3,653 Reduced 75.57%	1,181 $91,000
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $553 - $663	9 Added 0.19%	4,834 $353,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $54,434 - $63,457	-1,015 Reduced 17.38%	4,825 $301,000
Q3 2021 Nov 04, 2021	BUY	$59.17 - $69.31 $39,229 - $45,952	663 Added 12.81%	5,840 $346,000
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $49,961 - $54,407	807 Added 18.47%	5,177 $346,000
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $474 - $533	8 Added 0.18%	4,370 $276,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $57,740 - $65,430	1,000 Added 29.74%	4,362 $271,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $92,268 - $120,356	1,875 Added 126.09%	3,362 $216,000
Q1 2019 Apr 23, 2019	SELL	$45.12 - $53.8 $31,584 - $37,660	-700 Reduced 32.01%	1,487 $71,000
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $24,380 - $31,615	-500 Reduced 18.61%	2,187 $114,000
Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $8,278 - $9,337	-150 Reduced 5.29%	2,687 $167,000
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $11,419 - $14,233	-226 Reduced 7.38%	2,837 $157,000
Q4 2017 Feb 01, 2018	BUY	$59.94 - $65.35 $67,012 - $73,061	1,118 Added 57.48%	3,063 $188,000
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $107,422 - $123,974	1,945	1,945 $124,000

Others Institutions Holding BMY

# of Institutions

2,449

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.

Account

Tradewinds Capital Management, LLC Bristol Myers Squibb CO Transaction History